Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Dimetapp Chest Congestion Paediatric Drops
Active Ingredient: Guaiphenesin 20mg/mL
Dosage Form: Syrup
New Zealand Sponsor: Wyeth Consumer Healthcare A Division of Wyeth (NZ) Limited
Manufacturers: Interphil Laboratories Inc, Pittland, Cabuyao, Laguna, Philippines
Sigma Pharmaceuticals Pty Limited, Clayton, Victoria, Australia
Product: Eloxatin
Active Ingredient: Oxaliplatin 5mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturer: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Product: Septanest
Active Ingredients: Adrenaline acid tartrate 10µg/mL
Articaine hydrochloride 40mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Ivoclar Vivadent Limited
Manufacturer: Laboratoires Septodont, Saint-Maur-des-Fosses, Val-de-Marne, France
Dated this 27th day of January 2006.
BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).